Results 71 to 80 of about 7,910,350 (288)

Time to Progression of Prostate Cancer on Androgen Deprivation Therapy and Response Correlation with Gleason Score and PSA Value

Advanced Medical Journal
Background and Objectives: Prostate cancer progression is influenced by Gleason scores and prostate-specific antigen levels. This study aims to find the association between these markers and the duration until disease progression in patients undergoing ...
Krestiyan Manuail, Jang Muhialdin, Fahmi Salih   +2 more
doaj   +1 more source

Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level

Aging and Cancer, EarlyView.
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley   +1 more source

Development of prostrate cancer vaccine using PAP as target antigen [PDF]

, 2014
Treatment options for patients with advanced prostate cancer (PC) still remain limited and rarely curative. The prostatic acid phosphatase (PAP) is prostate specific protein over-expressed in more than 90% of prostate tumours.
Javad, JMS
core  

Covalent Functionalization of 2D Semiconductors: A Roadmap to Advanced Electronic Devices

Advanced Functional Materials, EarlyView.
This Review presents recent advances in the covalent functionalization strategies for two‐dimensional semiconductors and their implementation in modern technologies. Layered materials are modified through diverse molecular chemistries (e.g., thiols, diazonium salts, alkyl halides, and electron‐deficient species) to tailor their surface properties ...
Ramiro Quirós‐Ovies, Bin Han, Paolo Samorì   +2 more
wiley   +1 more source

Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth

, 2006
PURPOSE: The antiproliferative effects of pharmacological agents used for androgen ablative therapy in prostate cancer, including goserelin, bicalutamide and cyproterone acetate (Fluka Chemie, Buchs, Switzerland), were tested in vitro.
Peternac, Daniel, Studer, Urs E, Klima, Irena, Cecchini, Marco G, Thalmann, George N   +4 more
core   +1 more source

How is Nanoarchitectonics Shaping Extracellular Vesicle Research?

Advanced Healthcare Materials, EarlyView.
The convergence of nanoarchitectonics and extracellular vesicle biology is reshaping next‐generation nanomedicine by enabling rationally designed nanostructures for enhanced EVs detection, engineering, and therapy. ABSTRACT Extracellular vesicles (EVs) have gained recognition as crucial mediators of cell‐to‐cell communication, holding immense potential
Madushani Dahanayake, Md Shahriar A. Hossain, Chia‐Hung Liu, Carlos Salomon, Yusuke Yamauchi, Mostafa Kamal Masud   +5 more
wiley   +1 more source

Bounce effect or local recurrence after low-dose-rate brachytherapy of the prostate? When prostate-specific membrane antigen positron emission tomography–computed tomography is false positive: a case report

Journal of Medical Case Reports
Introduction Low-dose-rate brachytherapy has been increasingly utilized as a minimally invasive treatment option in patients with low- and intermediate-risk prostate cancer.
Tamas Rozsos, Daniel S. Engeler, Hans-Peter Schmid, Christoph Schwab   +3 more
doaj   +1 more source

From Cell‐Derived Vesicles to Hybrid Nanovectors: Biological Membranes as Functional Blueprints for Gene Delivery

Advanced Healthcare Materials, EarlyView.
Biologically derived and hybrid nonviral nanovectors are examined as distinct but convergent design approaches. Integrating synthetic components with biologically functionalized membranes allows efficient interactions with complex cellular environments.
Clara Baldari, Claudia Leone, Gabriella Leccese, Claudia De Stradis, Alessandra Invidia, Concetta Quintarelli, Biagio De Angelis, Franco Locatelli, Giuseppe Gigli, Gabriele Maiorano, Ilaria Elena Palamà   +10 more
wiley   +1 more source

Prostate specific antigen criteria to diagnose failure of cancer control following focal therapy of nonmetastatic prostate cancer using high Intensity focused ultrasound [PDF]

, 2020
PURPOSE: We determined whether prostate specific antigen criteria after focal high intensity focused ultrasound to treat prostate cancer could diagnose treatment failure.
Persad, Raj, Hosking-Jervis, Feargus, Huber, Philipp Markus, Afzal, N, Odgen, C, Persad, R, Moore, CM, Afzal, Naveed, Ahmed, Hashim U, Huber, PM, Thalmann, George N, Guillaumier, S, Boxler, S, Nigam, R, Emberton, M, Hindley, RG, Huber, Philipp M, Leemann, Lucas, Hosking-Jervis, F, Emberton, Mark, Winkler, M, Dudderidge, T, Virdi, Jaspal, Virdi, J, Hindley, Richard G, Lewi, Henry, Moore, Caroline M, Boxler, Silvan, Dudderidge, Tim, Leemann, L, McCartan, Neil, Odgen, Chris, Guillaumier, Stephanie, Nigam, Raj, Arya, Manit, Winkler, Mathias, Arya, M, Ahmed, HU, Thalmann, GN, Lewi, H, McCartan, N, Thalmann, George   +41 more
core   +2 more sources

PROSTATE SPECIFIC ANTIGEN AFTER TRANSURETHRAL RESECTION OF PROSTATE

Urology Research and Practice, 2019
-
Doğan ERDEN, Temuçin ŞENKUL, Kenan KARADEMİR, Bilal Fırat ALP   +3 more
doaj   +2 more sources